| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/26/2007 | CN100339071C Application of diacyl thiourea derivative in preparing antiviral medicine |
| 09/26/2007 | CN100339069C Formulation comprising thymol useful in treatment of drug resistant bacterial infections |
| 09/26/2007 | CN100339018C Nutritious compositions for detoxification and cancer prevention |
| 09/25/2007 | US7273928 Nucleic acid molecule comprising a nucleic acid sequence coding for a haemocyanin |
| 09/25/2007 | US7273920 Controlling protein levels in eucaryotic organisms |
| 09/25/2007 | US7273885 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 09/25/2007 | US7273873 Camptothecins with a modified lactone ring |
| 09/25/2007 | US7273872 alpha 7 receptor is the alpha -bungarotoxin sensitive receptor that influences the release of proinflammatory cytokines from macrophages |
| 09/25/2007 | US7273863 Benzophenones as inhibitors of reverse transcriptase |
| 09/25/2007 | US7273861 Non-nucleoside reverse transcriptase inhibitors |
| 09/25/2007 | US7273858 Salts |
| 09/25/2007 | US7273856 Antagonist of tachykinins like neurokinins and drugs |
| 09/25/2007 | US7273852 Synthetic C-glycolipid and its use for treating cancer, infectious diseases and autoimmune diseases |
| 09/25/2007 | US7273846 Selective melanin-concentrating hormone type-1 receptor agonists |
| 09/25/2007 | US7273752 Expression vector wherein said expression vector comprises a polynucleotide promoter sequence, a polynucleotide encoding a signal sequence, a polynucleotide encoding an antigen protein or peptide, a polynucleotide encoding a cell binding element, |
| 09/25/2007 | US7273751 Comprises nucleotide sequences associated with expression vector coding endothelial growth factor for use in diagnosis and treatment of tumor angiogenesis, inflammation, diabetic retinopathy, arthritis and psoriasis; wound healing agent |
| 09/25/2007 | US7273744 Heparanase-like polypeptides |
| 09/25/2007 | US7273614 Inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells. |
| 09/25/2007 | US7273611 Proteinase K resistant surface protein of neisseria meningitidis |
| 09/25/2007 | US7273605 Containing a priming and boosting composition, each with a non-replicating viral vector, with at least one of them being derived from a fowlpox virus; malaria, tuberculosis |
| 09/25/2007 | US7273602 Immunotherapy for humans |
| 09/25/2007 | CA2511753C Phospholipid derivatives |
| 09/25/2007 | CA2415551C Aniline derivatives |
| 09/25/2007 | CA2403026C Process for the preparation of 6-o-propargyl erythromycin derivatives |
| 09/25/2007 | CA2398848C Anti-infective agents useful against multidrug-resistant strains of bacteria |
| 09/25/2007 | CA2294649C Bovine adenovirus type 3 genome |
| 09/25/2007 | CA2285004C Stable glycerin iodine concentrate compositions |
| 09/25/2007 | CA2266486C Rotavirus vaccine formulations |
| 09/25/2007 | CA2204160C Treatment of urogenital cancer with boron neutron capture therapy |
| 09/25/2007 | CA2200967C Pharmaceutical compositions |
| 09/25/2007 | CA2177257C Condensation polymer of an aromatic sulfonic acid and an aldehyde for inhibiting hiv infectivity |
| 09/20/2007 | WO2007106622A2 Fungicidal formulation and method of use |
| 09/20/2007 | WO2007105984A1 Antimicrobial agent |
| 09/20/2007 | WO2007105637A1 Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient |
| 09/20/2007 | WO2007105581A1 Antimicrobial agent and antimicrobial composition |
| 09/20/2007 | WO2007105565A1 Peptide for inhibition of influenza infection, inhibitor of influenza infection, liposome, and prophylactic/therapeutic agent for influenza |
| 09/20/2007 | WO2007105551A1 Novel pyridine derivative having anti-helicobacter pylori activity |
| 09/20/2007 | WO2007105154A2 Antibiotic compounds |
| 09/20/2007 | WO2007105015A2 DERIVATIVES OF 18ß-GLYCYRRHETINIC ACID |
| 09/20/2007 | WO2007104933A1 Chemical compounds |
| 09/20/2007 | WO2007104932A2 Peptides of regulatory or accessory proteins of hiv, compositions and the utilization thereof |
| 09/20/2007 | WO2007104768A2 Di-polymer protein conjugates and processes for their preparation |
| 09/20/2007 | WO2007104519A1 Use of specific hydrazone compounds for the treatment viral infections |
| 09/20/2007 | WO2007104474A1 Antifungal compositions comprising (1) a salt of terbinafine with malic acid and (2) malic acid |
| 09/20/2007 | WO2007104263A1 An enhancin of hepatitis b virus vaccine and its gene |
| 09/20/2007 | WO2007104254A1 A type of new pyrimidine derivatives having small molecule, preparation methods and uses thereof |
| 09/20/2007 | WO2007104242A1 Compounds capable of inhibiting zinc ion metalloproteinases |
| 09/20/2007 | WO2007104070A1 Method and composition for treating allergic diseases |
| 09/20/2007 | WO2007082922A3 Long term treatment of hiv- infection with tcm278 |
| 09/20/2007 | WO2007079715A3 Novel lysolipin derivatives |
| 09/20/2007 | WO2007079457A3 Materials and methods for immunizing against fiv infection |
| 09/20/2007 | WO2007048122A3 Antibody-based therapeutics with enhanced adcc activity |
| 09/20/2007 | WO2007046125A3 Use of extracts of myrtle and other mediterranean plant species, as antimycotic agent towards yeast and yeast-like microorganisms |
| 09/20/2007 | WO2006130626A3 Method for modulating activity of hcv protease through use of a novel hcv protease inhibitor to reduce duration of treatment period |
| 09/20/2007 | WO2006130554A3 Methods of treating hepatitis c virus |
| 09/20/2007 | WO2005027871A3 Method for production of bioresorbable microparticles microparticles thus obtained and use thereof |
| 09/20/2007 | WO2005019190A3 (4 -amino -1,2, 5-oxadiazol-4-yl) -hetξroaromatic compounds useful as protein kinase inhibitors |
| 09/20/2007 | US20070219347 Meningitidis B serogroup; amino acid sequence encoded by nucleotides 564043 to 565882 of sequence 1; monoclonal antibodies; vaccine antigens |
| 09/20/2007 | US20070219231 Quinolonecarboxylic acid compounds, preparation methods and pharmaceutical uses thereof |
| 09/20/2007 | US20070219191 3-Pyridinium Methyl Cephem Compound |
| 09/20/2007 | US20070219159 Cyclodextrin compositions and methods of treating viral infections |
| 09/20/2007 | US20070219151 Methods and compositions for inhibiting the function of polynucleotide sequences |
| 09/20/2007 | US20070219149 Novel Vaccine Containing Adjuvant Capable Of Inducing Mucosal Immunity |
| 09/20/2007 | US20070219148 Small Interfering RNA Specific to Sub-Units $g(a),$g(a)' and $g(b) of the Kinase Protein ck2,and the Applications of the Same |
| 09/20/2007 | US20070219123 Selective n-acylation of a82846 glycopeptide analogs |
| 09/20/2007 | US20070219118 Therapeutic methods for nucleic acid delivery vehicles |
| 09/20/2007 | US20070218523 Modified human thymic stromal lymphopoietin |
| 09/20/2007 | US20070218077 Lipid-Mediated Polynucleotide Administration to Deliver a Biologically Active Peptide and to Induce a Cellular Immune Response |
| 09/20/2007 | US20070218052 Novel lgG3 Antibodies for Stimulating Phagocytosis |
| 09/20/2007 | US20070218036 Method For The Prevention Of Infection With Nodavirus And Method For The Treatment Thereof |
| 09/20/2007 | US20070218033 Composition and method of treating hepatitis C |
| 09/20/2007 | DE10216719B4 N-(3-Rifamycinyl)carbamate, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Behandlung und Verhütung von Tuberkulose N- (3-Rifamycinyl) carbamates, process for their preparation and their use in the treatment and prevention of tuberculosis |
| 09/20/2007 | DE102006042516A1 Verringerung eines Risikos für allerg. Reducing risk for Allergic Rhinitis. und Überempfindlichkeitsreaktionen bei Applikation des Arzneimittels Tobramycin Injektions- bzw. Infusionslösung aufgrund einer Natriummetabisulfitfreien Darreichungsform and hypersensitivity reactions in application of the drug tobramycin injection or infusion solution due to a dosage form Natriummetabisulfitfreien |
| 09/20/2007 | CA2649261A1 Influenza infection-inhibiting peptide, influenza virus-infection inhibitor, liposome and influenza preventive/therapeutic agent |
| 09/20/2007 | CA2646419A1 Use of the long pentraxin ptx3 for the prevention or treatment of viral diseases |
| 09/20/2007 | CA2645342A1 Peptides of regulatory or accessory proteins of hiv, compositions and the utilization thereof |
| 09/20/2007 | CA2644389A1 Pharmaceutical combinations of hcv-protease and -ires inhibitors |
| 09/20/2007 | CA2644368A1 Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient |
| 09/20/2007 | CA2643962A1 Antibiotic compounds |
| 09/19/2007 | EP1835021A1 Novel strain conferring anti-disease properties to host and bacterial cell composition |
| 09/19/2007 | EP1834963A1 Di-polymer protein conjugates and processes for their preparation |
| 09/19/2007 | EP1834961A2 Design of chemokine analogs for the treatment of human diseases |
| 09/19/2007 | EP1834959A2 Tert-butyl-substituted aromatic steroids having cytoprotective activity |
| 09/19/2007 | EP1834947A2 3-substituted amino-1H-indole-2-carboxylic acid and 3-substituted amino-benzo[B]thiophene-2carboxylic acid derivatives as interleukin-4 gene expression inhibitors |
| 09/19/2007 | EP1834669A1 Use of specific hydrazone compounds for the treatment of viral infections |
| 09/19/2007 | EP1834642A2 2-thioxothiazolidin-4-one compounds and compositions as antimicrobial and antimalarial agents targeting enoyl-ACP reductase of type II fatty acid synthesis pathway and other cell growth pathways |
| 09/19/2007 | EP1833978A1 Tripeptide and tetrapeptide thioethers |
| 09/19/2007 | EP1833844A1 Signal peptides, nucleic acid molecules and methods of treatment |
| 09/19/2007 | EP1833842A1 Tripeptide and tetrapeptide sulfones |
| 09/19/2007 | EP1833832A1 Napthyridine compounds as rock inhibitors |
| 09/19/2007 | EP1833510A2 Orally deliverable and anti-toxin antibodies and methods for making and using them |
| 09/19/2007 | EP1833474A1 Pharmaceutical compositions based on fluorinated sulphamides and sulphinimides |
| 09/19/2007 | EP1750765B1 Antimycobacterial pharmaceutical composition comprising an antitubercular drug |
| 09/19/2007 | EP1664025B1 Pyrrol derivatives with antibacterial activity |
| 09/19/2007 | EP1499605B1 NF-KappaB INHIBITORS |
| 09/19/2007 | EP1474396B1 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof |
| 09/19/2007 | EP1408911B1 Sustained-release therapeutic bioadhesive systems |
| 09/19/2007 | EP1407044B1 Rna interference mediating small rna molecules |
| 09/19/2007 | EP1326990B1 Packaging of positive-strand rna virus replicon particles |
| 09/19/2007 | EP1309590B1 Azaindole derivatives, process for their preparation, and their use as antitumor agents |